Betula Verrucosa (108)

3 trials VVarious

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

0 Recruiting

2 Completed trials

2 Sponsors

1 Countries

Phase II/III

Phase II

Phase II/III: 2 Phase II: 1

Sponsors using this IMP

ROXALL Medizin GmbH 2 Klinikum der Technischen Universitaet Muenchen (TUM Klinikum) 1

All trials

3 total

Sublingual Birch Immunotherapy for Pollen-associated Food Allergy Pending

2025-523653-34-00 Phase II 1 country Klinikum der Technischen Universitaet Muenchen (TUM Klinikum)
Phase II-III study to assess the efficacy and safety of sublingual immunotherapy in patients suffering from grass pollen allergy Ended

2023-505880-35-00 Phase II/III 1 country ROXALL Medizin GmbH
Phase II-III study to assess the efficacy and safety of sublingual immunotherapy in patients suffering from birch pollen allergy Ended

2023-505567-37-00 Phase II/III 1 country ROXALL Medizin GmbH

Showing 1–3 of 3 trials

← All drugs A–Z